Don Sellers



Mr. Sellers is a pharmaceutical and biotechnology executive with over 37 years of management experience including extensive international success. Active as a consultant, he currently is the Chief Executive Officer and Chairman of CardioPharma, Inc., a cardiovascular company start-up, board member of Certus, Inc., an oncology company start-up, on the Business Advisory Board of WI Harper, a San Francisco and Asian based investment group, and a member of Life Science Angels, a San Francisco Bay Area angel investing group. From 1993 to 2004, Mr. Sellers served as President, Chief Executive Officer and a director of SciClone Pharmaceuticals, Inc., a public company. While at SciClone he also established a profitable international subsidiary and created the clinical and marketing programs that resulted in the highly successful marketing of China’s leading imported finished pharmaceutical product, Zadaxin®. Prior to SciClone, Mr. Sellers’ global pharmaceutical industry experience included work with Pfizer, the Revlon Healthcare Group, a regional Presidency with Sterling Drug International and the Pritzker organization, where he served as a Corporate Vice-President focused on pharmaceuticals and biomed devices and President of Muller & Phipps Japan. Mr. Sellers spent five years in military intelligence serving as an officer with Special Forces and as a counter-intelligence Special Agent.

Mr. Sellers received an A.B. degree from Lafayette College and a Master of International Management degree with honors from the Thunderbird Graduate School of International Management